Cannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in New York to expand CNBX in Mental Health Diseases
Ryan Allway September 21st, 2021 Psychedelics TEL AVIV, Israel and BETHESDA, Maryland, Sept. 21, 2021 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the hire of Dr. David Sans FAARM, PhD, MBA in New York to expand its current pipeline of clinical development assets in Mental... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )